Persistent Asset Partners Ltd

Position in RLAY — Relay Therapeutics, Inc.

CIK 2056052 HONG KONG, K3

Back to RLAY Full portfolio

Position in RLAY

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,322,665

+$1,159,903 QoQ

Shares Held

70,693

+332.2% QoQ

Ownership

0.032%

of shares outstanding

% of Portfolio

0.44%

of 13F equity value

Holder Rank

#120

of 256 holders

Holding Since

Dec 2024

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in RLAY Over Time

Shares Held

Position Value (USD)

Derivatives in RLAY

reported options exposure · as of Dec 31, 2024

CallValue

$1,248

CallShares

303

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Persistent Asset Partners Ltd holds $74,585,923 across 142 Biotechnology names. RLAY ranks #12 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	38,726	$7,252,604
2	ABVX	Abivax S.A.	44,256	$5,897,553
3	COGT	Cogent Biosciences, Inc.	138,272	$5,351,125
4	BMRN	Biomarin Pharmaceutical Inc	79,933	$4,573,766
5	VKTX	Viking Therapeutics, Inc.	112,736	$4,397,831
6	EWTX	Edgewise Therapeutics, Inc.	69,441	$2,821,387
7	KOD	Kodiak Sciences Inc.	56,052	$2,183,785
8	IMCR	Immunocore Holdings plc	65,214	$2,070,544

All Filings in RLAY

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,322,665	70,693	+332.2%	Shares	Sole	2026-08-07
2026-03-31	$162,762	16,358	+59.1%	Shares	Sole	2026-05-12
2025-06-30	$35,568	10,280	-89.8%	Shares	Sole	2025-08-11
2025-03-31	$263,268	100,484	-31.1%	Shares	Defined	2025-05-13
2024-12-31	$600,811	145,828	—	Shares	Other	2025-02-14
2024-12-31	$1,248	303	—	Call	Other	2025-02-14
No filing history on record for this holder in this stock.